1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Senn, H.
Klaus, W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
232
907
925
10.1006/jmbi.1993.1439
8355277
The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor.
1993
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
232
897
Determination of the Disulphide Bonding Pattern in Proteins by Local and Global Analysis of Nuclear Magnetic Resonance Data: Application to Flavoridin
1993
10.2210/pdb1fvl/pdb
pdb_00001fvl
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7672.710
FLAVORIDIN
1
nat
polymer
no
no
GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL
GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Trimeresurus
sample
88087
BLOOD
Trimeresurus flavoviridis
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1996-01-29
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1995-09-06
REL
REL
18
GLY
1
n
1
GLY
1
A
GLU
2
n
2
GLU
2
A
GLU
3
n
3
GLU
3
A
CYS
4
n
4
CYS
4
A
ASP
5
n
5
ASP
5
A
CYS
6
n
6
CYS
6
A
GLY
7
n
7
GLY
7
A
SER
8
n
8
SER
8
A
PRO
9
n
9
PRO
9
A
SER
10
n
10
SER
10
A
ASN
11
n
11
ASN
11
A
PRO
12
n
12
PRO
12
A
CYS
13
n
13
CYS
13
A
CYS
14
n
14
CYS
14
A
ASP
15
n
15
ASP
15
A
ALA
16
n
16
ALA
16
A
ALA
17
n
17
ALA
17
A
THR
18
n
18
THR
18
A
CYS
19
n
19
CYS
19
A
LYS
20
n
20
LYS
20
A
LEU
21
n
21
LEU
21
A
ARG
22
n
22
ARG
22
A
PRO
23
n
23
PRO
23
A
GLY
24
n
24
GLY
24
A
ALA
25
n
25
ALA
25
A
GLN
26
n
26
GLN
26
A
CYS
27
n
27
CYS
27
A
ALA
28
n
28
ALA
28
A
ASP
29
n
29
ASP
29
A
GLY
30
n
30
GLY
30
A
LEU
31
n
31
LEU
31
A
CYS
32
n
32
CYS
32
A
CYS
33
n
33
CYS
33
A
ASP
34
n
34
ASP
34
A
GLN
35
n
35
GLN
35
A
CYS
36
n
36
CYS
36
A
ARG
37
n
37
ARG
37
A
PHE
38
n
38
PHE
38
A
LYS
39
n
39
LYS
39
A
LYS
40
n
40
LYS
40
A
LYS
41
n
41
LYS
41
A
ARG
42
n
42
ARG
42
A
THR
43
n
43
THR
43
A
ILE
44
n
44
ILE
44
A
CYS
45
n
45
CYS
45
A
ARG
46
n
46
ARG
46
A
ILE
47
n
47
ILE
47
A
ALA
48
n
48
ALA
48
A
ARG
49
n
49
ARG
49
A
GLY
50
n
50
GLY
50
A
ASP
51
n
51
ASP
51
A
PHE
52
n
52
PHE
52
A
PRO
53
n
53
PRO
53
A
ASP
54
n
54
ASP
54
A
ASP
55
n
55
ASP
55
A
ARG
56
n
56
ARG
56
A
CYS
57
n
57
CYS
57
A
THR
58
n
58
THR
58
A
GLY
59
n
59
GLY
59
A
LEU
60
n
60
LEU
60
A
SER
61
n
61
SER
61
A
ASN
62
n
62
ASN
62
A
ASP
63
n
63
ASP
63
A
CYS
64
n
64
CYS
64
A
PRO
65
n
65
PRO
65
A
ARG
66
n
66
ARG
66
A
TRP
67
n
67
TRP
67
A
ASN
68
n
68
ASN
68
A
ASP
69
n
69
ASP
69
A
LEU
70
n
70
LEU
70
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ASP
15
A
N
ASP
15
A
O
LYS
20
A
O
LYS
20
A
O
ARG
46
A
O
ARG
46
A
N
ASP
55
A
N
ASP
55
1
A
ARG
49
0.076
SIDE CHAIN
2
A
ARG
22
0.080
SIDE CHAIN
2
A
ARG
37
0.114
SIDE CHAIN
2
A
ARG
56
0.103
SIDE CHAIN
3
A
ARG
22
0.076
SIDE CHAIN
5
A
ARG
37
0.078
SIDE CHAIN
5
A
ARG
46
0.089
SIDE CHAIN
6
A
ARG
49
0.085
SIDE CHAIN
7
A
ARG
37
0.098
SIDE CHAIN
7
A
ARG
46
0.081
SIDE CHAIN
9
A
ARG
46
0.126
SIDE CHAIN
9
A
ARG
49
0.118
SIDE CHAIN
10
A
ARG
56
0.105
SIDE CHAIN
11
A
ARG
46
0.080
SIDE CHAIN
11
A
ARG
56
0.154
SIDE CHAIN
12
A
ARG
42
0.115
SIDE CHAIN
13
A
ARG
22
0.083
SIDE CHAIN
13
A
ARG
49
0.096
SIDE CHAIN
15
A
ARG
22
0.136
SIDE CHAIN
16
A
ARG
22
0.108
SIDE CHAIN
18
A
ARG
22
0.097
SIDE CHAIN
1
A
GLU
3
-144.18
25.82
1
A
ASP
5
-164.21
48.50
1
A
ALA
28
-96.32
-60.06
1
A
CYS
36
157.39
-35.06
1
A
LEU
60
-148.52
27.79
2
A
GLU
3
59.83
-179.42
2
A
ASP
15
58.20
-162.53
2
A
ALA
17
-168.85
-59.57
2
A
THR
18
-155.35
29.47
2
A
CYS
36
154.74
-32.25
2
A
ARG
42
92.34
-2.80
2
A
ARG
49
-103.62
74.03
2
A
ASN
68
-161.80
108.27
3
A
GLU
3
54.66
70.36
3
A
ASP
5
-152.00
56.22
3
A
THR
18
-166.50
64.76
3
A
CYS
19
-35.85
-32.52
3
A
GLN
35
31.68
48.53
3
A
CYS
36
165.28
-51.77
3
A
LYS
41
-58.47
177.73
3
A
ASP
51
-97.24
40.70
3
A
THR
58
-99.81
-66.94
3
A
ASP
69
51.10
83.88
4
A
ASP
5
-145.04
27.37
4
A
ALA
16
24.98
71.01
4
A
ALA
17
-158.24
-63.40
4
A
GLN
26
-146.33
23.37
4
A
GLN
35
31.03
57.81
4
A
LEU
60
-142.22
39.05
5
A
GLU
3
62.40
-179.59
5
A
CYS
4
66.74
120.56
5
A
SER
10
-96.57
40.86
5
A
ALA
17
-153.95
-57.69
5
A
CYS
19
75.96
-0.60
5
A
CYS
27
-170.80
-178.07
5
A
LEU
31
59.08
6.40
5
A
CYS
32
-151.25
25.93
5
A
CYS
36
171.73
40.04
5
A
ARG
37
-176.71
-174.64
5
A
ASP
51
-96.12
41.13
6
A
ASP
15
59.11
-173.65
6
A
ALA
17
-153.64
-58.04
6
A
THR
18
-160.66
31.61
6
A
CYS
19
79.77
-40.20
6
A
ALA
28
-127.69
-55.13
6
A
GLN
35
-82.54
45.97
6
A
CYS
36
171.80
-39.55
6
A
ARG
42
87.55
35.28
6
A
ASP
51
-104.48
43.73
7
A
GLU
2
-64.17
99.29
7
A
ASP
5
-150.66
35.06
7
A
CYS
6
-114.62
-75.12
7
A
THR
18
-157.10
60.50
7
A
CYS
32
-109.78
40.87
7
A
LYS
41
-56.07
177.00
7
A
ARG
49
-109.36
63.10
7
A
ASP
51
-101.81
43.02
7
A
CYS
57
-81.69
-159.03
8
A
GLU
3
-159.11
68.41
8
A
ASP
5
-148.34
28.26
8
A
ALA
16
27.37
69.01
8
A
ALA
17
-163.42
-70.34
8
A
GLN
35
32.51
42.35
8
A
CYS
36
159.30
-53.21
8
A
ARG
42
80.63
16.05
8
A
ASP
51
-94.92
38.29
8
A
LEU
60
-100.04
40.43
8
A
ASN
68
41.39
-148.73
9
A
CYS
19
76.31
-1.45
9
A
LEU
21
-46.53
151.59
9
A
GLN
35
31.37
44.89
9
A
CYS
36
154.34
-55.24
9
A
ARG
42
89.93
3.73
9
A
LEU
60
-159.65
28.36
9
A
ASP
69
-142.67
29.71
10
A
GLU
3
-160.38
64.80
10
A
ASP
5
-153.65
50.95
10
A
ALA
16
31.38
55.88
10
A
ALA
17
-167.46
-55.10
10
A
CYS
19
58.44
16.50
10
A
GLN
35
-80.14
47.51
10
A
CYS
36
157.32
-32.11
10
A
ARG
42
81.45
13.78
11
A
GLU
3
62.75
169.82
11
A
CYS
4
65.53
120.41
11
A
ASP
5
-156.73
42.77
11
A
ASP
34
-167.17
55.97
11
A
GLN
35
-171.97
41.08
11
A
ARG
37
-172.34
-172.20
11
A
LYS
40
60.75
170.27
11
A
ARG
42
83.33
33.39
11
A
CYS
57
-78.72
-169.48
11
A
ASN
68
-170.32
71.56
12
A
GLU
3
70.87
128.53
12
A
CYS
4
64.80
124.80
12
A
ASP
5
-150.10
41.90
12
A
ALA
16
29.30
62.00
12
A
ALA
17
-162.94
-65.43
12
A
GLN
35
32.72
43.19
12
A
CYS
36
165.42
-47.79
12
A
LYS
40
-49.36
160.50
12
A
ARG
42
85.26
16.23
12
A
ASP
51
-101.73
43.38
12
A
LEU
60
-140.68
16.82
13
A
CYS
6
-136.53
-86.57
13
A
SER
10
-89.33
39.22
13
A
GLN
35
32.34
55.66
13
A
ARG
37
-171.93
-171.14
13
A
LYS
41
-55.95
174.64
13
A
ASP
51
-100.06
41.62
13
A
LEU
60
-151.18
29.16
14
A
CYS
4
163.70
127.20
14
A
ASP
15
56.77
-173.16
14
A
ALA
17
-158.85
-58.16
14
A
THR
18
-160.12
32.05
14
A
CYS
19
79.11
-44.92
14
A
CYS
36
152.76
-29.75
14
A
ARG
37
-129.35
-167.86
14
A
ARG
42
82.53
16.66
14
A
ARG
49
-103.89
65.33
14
A
ASP
51
-103.33
43.44
14
A
ASN
68
31.73
-146.98
14
A
ASP
69
-98.06
42.07
15
A
ASP
5
-153.04
32.48
15
A
ALA
16
-98.86
36.43
15
A
ASP
29
-173.42
142.82
15
A
CYS
32
-149.77
25.78
15
A
GLN
35
31.75
42.71
15
A
CYS
36
154.96
-52.50
15
A
ARG
37
-103.10
-165.93
15
A
LEU
60
-88.15
39.11
16
A
GLU
2
-57.07
171.00
16
A
GLU
3
-161.39
102.55
16
A
ASP
15
53.31
-164.39
16
A
ALA
17
-165.45
-57.45
16
A
THR
18
-159.03
31.22
16
A
CYS
19
72.19
-1.19
16
A
ALA
28
-123.86
-57.67
16
A
CYS
36
153.01
-29.72
16
A
LYS
41
-60.73
-174.11
16
A
ARG
42
74.77
39.53
16
A
LEU
60
-87.70
33.60
17
A
GLU
2
-159.24
54.30
17
A
CYS
4
179.10
123.22
17
A
CYS
6
-135.01
-73.94
17
A
THR
18
-158.84
59.57
17
A
ASP
29
179.91
161.80
17
A
ASP
34
-157.07
53.80
17
A
GLN
35
-171.01
33.07
17
A
ARG
37
-170.13
-173.20
17
A
LYS
41
-59.21
178.66
17
A
ASP
51
-97.65
40.65
18
A
GLU
2
-162.35
66.66
18
A
GLU
3
67.70
137.87
18
A
CYS
4
63.50
116.38
18
A
ASP
5
-157.55
37.77
18
A
CYS
6
-115.63
-82.85
18
A
LEU
31
55.27
12.23
18
A
CYS
32
-150.78
-37.80
18
A
CYS
36
158.67
-32.87
18
A
LYS
41
-55.04
174.84
18
A
LEU
60
-96.74
41.79
18
A
ASN
68
-171.78
47.73
18
A
ASP
69
49.64
85.17
THE NUCLEAR MAGNETIC RESONANCE SOLUTION STRUCTURE OF FLAVORIDIN, AN ANTAGONIST OF THE PLATELET GP IIB-IIIA RECEPTOR
1
Y
N
disulf
2.092
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
19
A
SG
CYS
19
1_555
disulf
2.046
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
14
A
SG
CYS
14
1_555
disulf
2.019
A
CYS
13
A
SG
CYS
13
1_555
A
CYS
36
A
SG
CYS
36
1_555
disulf
2.013
A
CYS
27
A
SG
CYS
27
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.048
A
CYS
32
A
SG
CYS
32
1_555
A
CYS
57
A
SG
CYS
57
1_555
disulf
1.945
A
CYS
45
A
SG
CYS
45
1_555
A
CYS
64
A
SG
CYS
64
1_555
BLOOD COAGULATION INHIBITOR
GP IIB/IIIA ANTAGONIST, BLOOD COAGULATION INHIBITOR
DISF_TRIFL
UNP
1
1
P18619
GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL
1
70
1FVL
1
70
P18619
A
1
1
70
2
2
anti-parallel
anti-parallel
A
CYS
14
A
CYS
14
A
ASP
15
A
ASP
15
A
LYS
20
A
LYS
20
A
LEU
21
A
LEU
21
A
ILE
44
A
ILE
44
A
ARG
46
A
ARG
46
A
ASP
55
A
ASP
55
A
ARG
56
A
ARG
56
1
P 1